Search Within

Matthew J Matasar

Refine Results
Formats
  1. Meeting Abstract (75)
  2. Journal Article (40)
  3. Book Section (3)
  4. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (119)
  2. Hematologic Oncology, Division of (119)
  3. Lymphoma (119)
  4. Lymphoma Service (119)
  5. Population Sciences Research Program (119)
  6. Survivorship Research (119)

More Groups

People
  1. Craig Moskowitz (69)
  2. Andrew Zelenetz (52)
  3. David Straus (46)
  4. Paul Hamlin (45)
  5. Alison Moskowitz (44)
  6. Steven Horwitz (42)

More People

Years
  1. 2018 (14)
  2. 2017 (27)
  3. 2016 (17)
  4. 2015 (22)
  5. 2014 (12)
  6. 2013 (8)

More Years

Publications
  1. Blood (49)
  2. Journal of Clinical Oncology (14)
  3. Biology of Blood and Marrow Transplantation (10)
  4. Hematological Oncology (9)
  5. Annals of Oncology (3)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (50)
  2. Elsevier Inc. (15)
  3. American Society of Clinical Oncology (14)
  4. Wiley Blackwell (11)
  5. Oxford University Press (7)
  6. John Wiley & Sons (3)

More Publishers

Results (119)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A detailed evaluation of transplant-related toxicities and outcome for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, busulfan (Bu), cyclophosphamide (TBC) conditioning
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Blood (2015)

    Fulltext@MSK | Save
  • A prospective study of allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Perales, M. A.; Cho, C.; Eaton, A.; Moskowitz, A. J.; Nguyen, V.; Gonzales-Dadiz, A. M. R.; Devlin, S.; Giralt, S. A.; Jakubowski, A. A.; Matasar, M. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Differences in patients with progressive versus non-progressive AML, CLL, or NHL: Implications for proposed bundled payment strategies
    Meeting Abstract

    Byfield, S. D.; Engel-Nitz, N.; Bancroft, T.; Anderson, A. J.; Reyes, C.; Ravelo, A.; Ogale, S.; Chen, M.; Matasar, M. J.
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically (PK) directed busulfan in combination with thiotepa & cyclophosphamide (TBC) conditioning with HDT-ASCT in patients with primary & secondary CNS lymphoma
    Meeting Abstract

    Bhatt, V.; Scordo, M.; Hsu, M.; Omuro, A. M.; DeAngelis, L.; Lin, A.; Matasar, M. J.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Bantilan, K. S.; Verwys, S. L.; McCall, S. J.; Yahalom, J.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Toxicity of maintenance rituximab in older adults with non-Hodgkin lymphoma
    Meeting Abstract

    Matasar, M. J.; Atoria, C. L.; Elkin, E. B.; Nabhan, C.
    Blood (2015)

    Fulltext@MSK | Save
  • Survivorship care planning after participation in communication skills training intervention for a consultation about lymphoma survivorship
    Journal Article

    Banerjee, S. C.; Matasar, M. J.; Bylund, C. L.; Horwitz, S.; Mc Larney, K.; Levin, T.; Jacobsen, P. B.; Parker, P.; Astrow, A.; Kissane, D. W.
    Translational Behavioral Medicine (2015)

    Fulltext@MSK | Save
  • Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C. S.; Riviere, I.; Bernal, Y.; Wang, X. Y.; Purdon, T.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial
    Meeting Abstract

    Owens, C. N.; Iannotta, A.; Gerecitano, J. F.; Matasar, M. J.; Noy, A.; Moskowitz, C. H.; Drullinsky, P.; Palomba, M. L.; Straus, D. J.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save